PL2337575T3 - Sposoby leczenia z użyciem pojedynczych dawek orytawancyny - Google Patents

Sposoby leczenia z użyciem pojedynczych dawek orytawancyny

Info

Publication number
PL2337575T3
PL2337575T3 PL09810708.9T PL09810708T PL2337575T3 PL 2337575 T3 PL2337575 T3 PL 2337575T3 PL 09810708 T PL09810708 T PL 09810708T PL 2337575 T3 PL2337575 T3 PL 2337575T3
Authority
PL
Poland
Prior art keywords
oritavancin
treatment
methods
single doses
doses
Prior art date
Application number
PL09810708.9T
Other languages
English (en)
Inventor
Dario Lehoux
Thomas R. Parr
Gregory Moeck
Pierre Etienne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41722337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2337575(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL2337575T3 publication Critical patent/PL2337575T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
PL09810708.9T 2008-08-30 2009-08-29 Sposoby leczenia z użyciem pojedynczych dawek orytawancyny PL2337575T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9331408P 2008-08-30 2008-08-30
US9349708P 2008-09-02 2008-09-02

Publications (1)

Publication Number Publication Date
PL2337575T3 true PL2337575T3 (pl) 2016-09-30

Family

ID=41722337

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09810708.9T PL2337575T3 (pl) 2008-08-30 2009-08-29 Sposoby leczenia z użyciem pojedynczych dawek orytawancyny

Country Status (16)

Country Link
US (2) US8420592B2 (pl)
EP (2) EP2337575B1 (pl)
JP (1) JP5782615B2 (pl)
CN (2) CN106620649A (pl)
AU (1) AU2009285564B2 (pl)
CA (1) CA2736860C (pl)
DK (1) DK2337575T3 (pl)
EA (1) EA020490B1 (pl)
ES (1) ES2570401T3 (pl)
HU (2) HUE027373T2 (pl)
MX (1) MX2011002249A (pl)
NL (1) NL300834I2 (pl)
NO (1) NO2016019I2 (pl)
NZ (1) NZ591525A (pl)
PL (1) PL2337575T3 (pl)
WO (1) WO2010025438A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2570401T3 (es) * 2008-08-30 2016-05-18 The Medicines Co Métodos de tratamiento usando dosis únicas de oritavancina
EP2424559B1 (en) * 2009-04-28 2024-04-03 Melinta Therapeutics, LLC Methods of treating bacterial infections using oritavancin
WO2014031681A1 (en) * 2012-08-20 2014-02-27 The University Of Chicago Inhibiting gram positive bacteria
WO2014176068A2 (en) * 2013-04-22 2014-10-30 The Medicines Company Treatment and prevention of bacterial skin infections using oritavancin
FI3038616T3 (fi) 2013-08-26 2023-05-04 Melinta Therapeutics Inc Menetelmiä bakteremian ja osteomyeliitin hoitamiseksi oritavansiinia käyttämällä
US9775878B2 (en) * 2013-08-28 2017-10-03 The Medicines Company Methods for treating bacterial infections using oritavancin and polymyxins
US20170119793A1 (en) * 2014-06-12 2017-05-04 Cem-102 Pharmaceuticals, Inc. Compositions and methods for treating bone and joint infections
JP6712991B2 (ja) * 2014-07-17 2020-06-24 ザ メディシンズ カンパニー 高純度のオリタバンシン及びその製造方法
MX2018009948A (es) 2016-02-18 2018-12-06 Melinta Therapeutics Inc Formulaciones de oritavancina.
US20200171124A1 (en) * 2016-04-15 2020-06-04 Lupin Limited Topical compositions for ophthalmic and otic use
CN108409837B (zh) 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5994297A (en) * 1997-08-22 1999-11-30 Eli Lilly And Company Therapy for Staphylococcus aureus
TR200103211T2 (tr) * 1999-05-03 2002-02-21 Eli Lilly And Company Streptococcus pneumoniae enfeksiyonlarının tedavisi.
ATE416791T1 (de) 2000-05-02 2008-12-15 Theravance Inc Zusammensetzung die eine zyklodextrin und ein glykopeptid-antibiotikum enthält
US20030176327A1 (en) * 2001-10-25 2003-09-18 Cassell Gail Houston Antibiotics for treating biohazardous bacterial agents
BR0311413A (pt) * 2002-05-28 2005-03-22 Becton Dickinson Co Desenvolvimento e transdiferenciação de células acinares humanas
US20040147441A1 (en) * 2002-08-23 2004-07-29 Leach Timothy S. Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CA2664444C (en) * 2006-09-25 2015-10-27 Targanta Therapeutics Corp. Use of oritavancin for prevention and treatment of anthrax
ES2570401T3 (es) * 2008-08-30 2016-05-18 The Medicines Co Métodos de tratamiento usando dosis únicas de oritavancina
EP2424559B1 (en) * 2009-04-28 2024-04-03 Melinta Therapeutics, LLC Methods of treating bacterial infections using oritavancin
US9775878B2 (en) * 2013-08-28 2017-10-03 The Medicines Company Methods for treating bacterial infections using oritavancin and polymyxins

Also Published As

Publication number Publication date
NO2016019I2 (no) 2019-01-25
EA020490B1 (ru) 2014-11-28
AU2009285564A1 (en) 2010-03-04
HUS1600039I1 (hu) 2016-11-28
CN102215858A (zh) 2011-10-12
CA2736860C (en) 2020-04-28
AU2009285564B2 (en) 2014-05-22
WO2010025438A2 (en) 2010-03-04
JP2012501349A (ja) 2012-01-19
HUE027373T2 (hu) 2016-09-28
DK2337575T3 (en) 2016-05-23
US20130172237A1 (en) 2013-07-04
NO2016019I1 (no) 2016-10-11
US20110201546A1 (en) 2011-08-18
US8420592B2 (en) 2013-04-16
WO2010025438A9 (en) 2010-05-14
EP2337575A4 (en) 2012-10-17
EP2337575A1 (en) 2011-06-29
EA201100413A1 (ru) 2012-01-30
EP2337575B1 (en) 2016-04-13
CA2736860A1 (en) 2010-03-04
JP5782615B2 (ja) 2015-09-24
EP3006038A1 (en) 2016-04-13
NL300834I2 (pl) 2016-11-16
ES2570401T3 (es) 2016-05-18
CN106620649A (zh) 2017-05-10
MX2011002249A (es) 2011-06-24
NZ591525A (en) 2014-03-28

Similar Documents

Publication Publication Date Title
HUS1600039I1 (hu) Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával
HUS1600057I1 (hu) Kezelési eljárások ammónia-megkötõ hatóanyag alkalmazásával
IL208354A0 (en) Methods of treatment
HK1156631A1 (en) Novel compounds and methods for therapy
ZA201106730B (en) Methods of treatment using combination therapy
HRP20181877T1 (hr) Postupci za liječenje lijekovima koji uklanjaju amonijak
EP2350641A4 (en) Methods of Treatment
ZA201000225B (en) Treatment of depression
EP2424529A4 (en) NEW THERAPEUTIC TREATMENTS WITH CENTHAQUIN
EP2164494A4 (en) Methods of Treatment
GB0723100D0 (en) Treatment of HFnEF
EP2424539A4 (en) PROCESS FOR TREATING DEPRESSION
EP2440238A4 (en) Methods of Treatment
GB2460445B (en) Treatment of ringworm
SI2330892T1 (sl) Postopki zdravljenja z uporabo zdravil, ki odstranjujejo amoniak
GB0700969D0 (en) Methods of treatment
AU2008902372A0 (en) Methods of treatment
GB2465211B (en) Treatment Solution
GB0816217D0 (en) Treatment of hepatitis C
GB0823435D0 (en) Method of treatment
AU2009905173A0 (en) Methods of treatment
AU2009902633A0 (en) Methods of treatment
AU2009904460A0 (en) Methods of treatment
GB0804468D0 (en) Treatment of influenza